Gibson, Dunn & Crutcher advised Alcon Inc. on the deal, and Morrison & Foerster advised OcuMension Therapeutics. OcuMension Therapeutics (“OcuMension”), a Hong Kong-listed, China-based ophthalmic pharmaceutical...
Ocumension Therapeutics’ Acquisition of Alcon’s Rights
Hangzhou DAC Biotechnology’s Collaboration and License Agreement with Janssen
Morrison & Foerster LLP advised Hangzhou DAC Biotechnology Co. on the deal. Hangzhou DAC Biotechnology Co., Ltd. (“DAC Biotechnology”) announced its collaboration and license agreement with Janssen...